US Rare Disease Drug Sales Market Opportunity To Surpass USD 190 Billion By 2030 Says Kuick ResearchDelhi, Oct. 16, 2025 ...
A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is ...
Beam Therapeutics recently announced that its BEAM-302 program received FDA orphan drug designation, alongside encouraging updates for its gene-editing therapies targeting rare diseases such as sickle ...
The FDA has granted orphan drug status to the experimental T-cell, or Treg, therapy CK0803, being developed by Cellenkos to ...
The Congressional Budget Office said Monday that a provision in the GOP’s reconciliation bill that widened an exemption for ...
Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the USOrphan Drug Designation previously granted by the ...
An unnamed source clarified that Sandra Retzky has not been fired from the FDA, but it remains unclear where she was ...
The Congressional Budget Office says exemptions for orphan drugs as part of Medicare price negotiations will cost taxpayers ...
Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously granted by the European Medicines Agency in May 2025 ASHBURN, Va., Oct ...
TipRanks on MSN
Quoin Pharmaceuticals Receives FDA Orphan Drug Designation
Quoin Pharmaceuticals ( ($QNRX) ) has provided an update. On October 21, 2025, Quoin Pharmaceuticals announced that the U.S. FDA granted Orphan ...
The U.S. Congressional Budget Office said on Monday that new exemptions to drug price negotiations for several blockbuster ...
The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback